Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Marcus

Showing results (111-120 of 230) with videos related to

Pageof 23
Sort By:
Circulation|February 9, 2005
Magnetic resonance imaging predictors of coarctation severityJames C Nielsen, Andrew J Powell, Kimberlee Gauvreau, et al.
Learning Health Systems|July 19, 2021
Relational interventions for organizational learning: An experience reportN Marcus Thygeson, Caroline Logan, Curt Lindberg, et al.
Journal of Clinical Psychopharmacology|January 22, 2008
A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependenceRaymond F Anton, Henry Kranzler, Christopher Breder, et al.
The Journal of Clinical Psychiatry|October 27, 2007
Comparison of metabolic syndrome incidence among schizophrenia patients treated with aripiprazole versus olanzapine or placeboGilbert J L'Italien, Daniel E Casey, Hong J Kan, et al.
Journal of Psychiatric Research|July 17, 2007
A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophreniaJoseph P McEvoy, David G Daniel, William H Carson, et al.
Journal of Bioethical Inquiry|December 21, 2017
Minority Veterans Are More Willing to Participate in Complex Studies Compared to Non-minoritiesLeonardo Tamariz, Irene Kirolos, Fiorella Pendola, et al.
Clinical and Experimental Immunology|June 8, 2020
Late diagnosis of chronic granulomatous diseaseT Barkai, R Somech, A Broides, et al.
The Journal of Clinical Psychiatry|January 1, 1995
A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatientsJ Mendels, F Reimherr, R N Marcus, et al.
Biological Psychiatry|November 7, 2008
A double-blind, randomized comparative study of aripiprazole and olanzapine in patients with schizophreniaW Wolfgang Fleischhacker, Robert D McQuade, Ronald N Marcus, et al.
Journal of Women'S Health (2002)|February 19, 2016
Acceptability and Feasibility of Human Papilloma Virus Self-Sampling for Cervical Cancer ScreeningKumar Ilangovan, Erin Kobetz, Tulay Koru-Sengul, et al.
Pageof 23

Showing results (111-120 of 230) with videos related to

Sort By:
Pageof 23
Circulation|February 9, 2005
Magnetic resonance imaging predictors of coarctation severityJames C Nielsen, Andrew J Powell, Kimberlee Gauvreau, et al.
Learning Health Systems|July 19, 2021
Relational interventions for organizational learning: An experience reportN Marcus Thygeson, Caroline Logan, Curt Lindberg, et al.
Journal of Clinical Psychopharmacology|January 22, 2008
A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependenceRaymond F Anton, Henry Kranzler, Christopher Breder, et al.
The Journal of Clinical Psychiatry|October 27, 2007
Comparison of metabolic syndrome incidence among schizophrenia patients treated with aripiprazole versus olanzapine or placeboGilbert J L'Italien, Daniel E Casey, Hong J Kan, et al.
Journal of Psychiatric Research|July 17, 2007
A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophreniaJoseph P McEvoy, David G Daniel, William H Carson, et al.
Journal of Bioethical Inquiry|December 21, 2017
Minority Veterans Are More Willing to Participate in Complex Studies Compared to Non-minoritiesLeonardo Tamariz, Irene Kirolos, Fiorella Pendola, et al.
Clinical and Experimental Immunology|June 8, 2020
Late diagnosis of chronic granulomatous diseaseT Barkai, R Somech, A Broides, et al.
The Journal of Clinical Psychiatry|January 1, 1995
A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatientsJ Mendels, F Reimherr, R N Marcus, et al.
Biological Psychiatry|November 7, 2008
A double-blind, randomized comparative study of aripiprazole and olanzapine in patients with schizophreniaW Wolfgang Fleischhacker, Robert D McQuade, Ronald N Marcus, et al.
Journal of Women'S Health (2002)|February 19, 2016
Acceptability and Feasibility of Human Papilloma Virus Self-Sampling for Cervical Cancer ScreeningKumar Ilangovan, Erin Kobetz, Tulay Koru-Sengul, et al.
Pageof 23